Y. Sunwoo
Inje University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Y. Sunwoo.
Clinical Pharmacology & Therapeutics | 2007
J. Ryu; Im-Sook Song; Y. Sunwoo; Ji-Hong Shon; Kwang-Hyeon Liu; In-June Cha; J.-G. Shin
To develop and validate an in vivo cocktail method for high‐throughput phenotyping of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A, 12 healthy subjects received five probe drugs alone or simultaneously. The in vivo phenotyping index of CYP2C9, the ratio of 8 h urine concentration of losartan to its metabolite after a single administration of losartan, was not significantly different from that obtained using the five‐drug cocktail. Similarly, the ratios of [omeprazole]/[5‐hydroxyomeprazole] (CYP2C19) and [paraxanthine]/[caffeine] (CYP1A2) in 4 h plasma samples and the log ratio of [dextromethorphan]/[dextrorphan] (CYP2D6) in 8 h urine samples and the 4 h plasma concentrations of midazolam (CYP3A) after single administration or well‐established three‐drug cocktail of caffeine, omeprazole, and dextromethorphan were not significantly different from those after the new five‐drug cocktail. In conclusion, the new five‐drug cocktail regimen, named the “Inje cocktail,” can be used as a tool to phenotype in vivo enzyme activities of CYP1A2, CYP2C9, CYP2C19, CYP2D6, and CYP3A with only 4 h blood sampling and 8 h urine collection following simultaneous administration of the five probe drugs.
Drug Metabolism and Disposition | 2007
Su-Jun Lee; Sang Seop Lee; H. Jeong; Ji-Hong Shon; J. Ryu; Y. Sunwoo; Kwang-Hyeon Liu; Wonku Kang; Young-Ju Park; Chi-Mann Shin; Jae-Gook Shin
The objective of this study was to identify CYP3A4 variants in Koreans and to characterize their functional consequences in vitro and in vivo. Four single nucleotide polymorphisms were identified in 50 Koreans by direct DNA sequencing. In an additional genotyping using 248 subjects, CYP3A4*18 was confirmed as the most frequent coding variant in Koreans at 1.7%, and its frequency was similar to that of Asians, suggesting that CYP3A4*18 would be the highest coding variant in Asians. The recombinant CYP3A4.18 protein prepared in baculovirus expression system showed 67.4% lower Vmax and 1.8-fold higher Km for midazolam 1′-hydroxylation compared with the wild type. The mean values of Cmax and area under the concentration curve (AUC) in the CYP3A4*1/*18 and CYP3A5*1/*3 subjects (n = 8) were 63% and 32% higher than in CYP3A4*1/*1 and CYP3A5*1/*3 carriers (n = 8), respectively. Although the in vitro assay exhibited a significant reduction of the enzyme activity for midazolam, the in vivo differences associated with the CYP3A4*1/*18 tend to be low (P < 0.07 in Cmax and P < 0.09 in AUC). In summary, the heterozygous CYP3A4*1/*18 does not appear to cause a significant change of midazolam disposition in vivo; however, the clinical relevance of CYP3A4*18/*18 remains to be evaluated.
Xenobiotica | 2008
W. Pan; J. Ryu; Ji-Hong Shon; Im-Sook Song; Kwang-Hyeon Liu; Y. Sunwoo; W. Kang; J.-G. Shin
To evaluate the effects of dietary salt on the stereoselective disposition of verapamil enantiomers in relation to the transporter ABCB1 2677GG/3435CC and 2677TT/3435TT haplotypes, ten healthy subjects were asked to take diets of three different salt levels for 7 days in a randomized, three-way crossover manner. The plasma concentrations of verapamil and norverapamil enantiomers were determined after a single oral dose of 240 mg verapamil on the last day of each phase. Pharmacokinetic parameters were calculated by non-compartmental analysis techniques and compared among the three different dietary salt phases. Compared with the medium salt diet, the high and low salt diets had no significant effect on the disposition of verapamil enantiomers. Moreover, the ABCB1 haplotypes did not alter the impact of dietary salt, although ABCB1 2677TT/3435TT subjects had slightly, but not significantly, higher Cmax and area under the curve (AUC) and lower Tmax for the verapamil enantiomers than did 2677GG/3435CC subjects in each salt phase.
Clinical Pharmacology & Therapeutics | 2004
Y. Sunwoo; J. Ryu; Hyun-Ju Jung; W. Kang; Kwang-Hyeon Liu; Y. Yoon; Sung-Soon Lee; J Shin
Cytochrome P450 2D6 (CYP2D6) represents a variety of polymorphism. CYP2D6*10B, an allelic variant shown with a high frequency in Asian compared with Caucasian has been reported to decrease the enzyme activity. The effect of CYP2D6*10B allele was investigated on the pharmacokinetics of chlorpromazine (CPZ) in Korean healthy subjects.
Clinical Pharmacology & Therapeutics | 2006
E Kim; Ji-Hong Shon; J Ryu; Y. Sunwoo; J Jang; K Song; B Moon; S Joo; J Shin
To evaluate the effect of revaprazan, novel gastric acid antagonist, on human endocrine functions, in randomized, double‐blind, crossover design, 200mg revaprazan or placebo were given orally to 13 male volunteers for 1 week with 2‐weeks washout. On the days before and after each treatment course, serum concentrations of tri‐iodothyronine (T3), thyroxine (T4), thyroid‐stimulating hormone (TSH), follicle‐stimulating hormone (FSH), and luteinizing hormone (LH) were measured, followed by TSH and LH response tests to thyrotropin releasing hormone (TRH) and luteinizing hormone releasing hormone (LHRH).
Clinical Pharmacology & Therapeutics | 2005
J. Ryu; Y. Sunwoo; M. Go; P. M. Nauyen; Kwang-Hyeon Liu; J Shin
Epimedium koreanum is popular herbal medicine in Korea. Our previous in vitro study has showed that epimedium has a marked inhibitory potential on the activity of cytochrome P450(CYP) isoforms, CYP1A2, 2C19, 2D6, and 3A. The effect of epimedium on CYP activity in vivo was assessed using the cooperstown cocktail regimen. Eight healthy male subjects received cocktail regimen including caffeine, omeprazole, dextromethorphan, and iv midazolam to determine the baseline activities before herbal supplementation(day1). After a week, dried water extract of epimedium was administered for 7days. The cocktail study was conducted on day 8 with first coadministration of epimedium and did again on day 15 after completion of herbal supplementation. Blood samples were drawn serially upto 12 hrs and urine was collected upto 24 hrs after dosing. Midazolam clearance, caffeine (paraxanthine/caffine AUCinf) and omeprazole (OH‐omeprazole/omeprazole AUCinf) metabolic ratio were not significantly different from baseline. The urinary Log(dextromethorphan/dextrophan) ratio after epimedium supplementation for 7 days was significantly decreased from baseline. First coadministration of epimedium did not show to have an effect on any CYPs metabolic ratio. This result indicates that long‐term treatment of epimedium may induce the CYP2D6 enzyme activity in vivo. However, the in vivo activity of other CYPs was found to be not appreciably influenced by epimedium administration despite its in vitro inhibitory potential.
Clinical Pharmacology & Therapeutics | 2005
Y. Sunwoo; J. Ryu; Ji-Hong Shon; J. Kwak; Dong-Jun Lee; P. M. Nguyen; Sung-Soon Lee; Kwang-Hyeon Liu; J Shin
Capsaicin, a major ingredient of hot pepper, has been known to affect on activities of several CYP isoenzymes. To evaluate the effect of hot pepper on activities of CYP2A6 and other CYPs, 7 healthy subjects predetermined to have no CYP2A6, 2C19 and 2D6 genetic variation reported previously were enrolled in randomized crossover study. In the restriction period, food containing hot pepper was completely restricted for 7 days. In other period, meal containing 5g of hot pepper was served three times a day for 7 days. On each 6th day, cocktail study including PO caffeine, omeprazole, and dextromethophan, and IV midazolam was conducted. On 7th day, nicotine (2mg) gum was chewed for 30 min. Blood and urine were serially collected for 12 hrs after dosing. Concentrations of probes and their metabolites in plasma and urine were measured using LC/MS/MS and HPLC. The AUC12hr ratio of cotinine to nicotine was higher in hot pepper rich diet than in the restriction period. The t1/2of nicotine was shortened (8.7±6.3hr vs 3.7±1.8hr, p<0.05) and total clearance was increased significantly (1.0±0.5 vs 1.6±0.6L/kg/hr, p<0.05) after hot pepper rich diet. The metabolic ratio of other CYP isoforms was not significantly changed after hot pepper rich. Diet containing high content of hot pepper seems likely to increase CYP2A6 activity, but not other CYPs. Higher CYP2A6 activity in Korean may be contributed by high intake of hot pepper rich foods. This might imply that high smoking rates in Korean population is related with intake of hot pepper.
Clinical Pharmacology & Therapeutics | 2005
J. Ryu; Y. Sunwoo; Ji-Hong Shon; Dong-Jun Lee; Kwang-Hyeon Liu; In-June Cha; J Shin
Although the effect of MDR1 genotype on oral bioavailability of verapamil are remained controversial, dietary salt might affect on its disposition in relation to MDR1 genetic polymorphism. To evaluate the influences of dietary salt on the enantioselective disposition of verapamil in relation to MDR1 genotype, ten healthy male subjects(5 with 3435CC/2677GG and others with 3435TT/2677TT) were enrolled in randomized crossover study. Five were served low salt diet (~1.5g/day) and others did high salt diet (25g/day) for 7 days. After a week‐washout, the salt diet sequence was switched. On day 7, 14, and 21, blood and urine samples were serially collected upto 24 hours after oral dosing of 240mg verapamil. The concentration of verapamil enantiomers and its metabolites were determined using LC/MS/MS. The plasma concentrations of both enantiomers and R/S AUCinf ratios were not significantly different between trials of each diet in both genotype group. Cmax, AUC0–4hr, and AUCo‐∞ of verapamil in subjects with 3435TT/2677TT were higher than in those with 3435CC/2677GG in both trial, but the difference was not statistically significant. The R/S AUCinf ratio was not also significantly different between MDR1 genotype groups. These results did not demonstrate that the dietary salt affects on the disposition of verapamil. However, this study indicated that subject with MDR1 3435T/2677T variant might show the higher oral bioavailability of verapamil than those with MDR1 3435C/2677G due to low P‐glycoprotein activity.
Clinical Pharmacology & Therapeutics | 2004
Kyung-Ah Kim; Y. Sunwoo; J. Ryu; Sung-Soon Lee; Y. Yoon; In-June Cha; J Shin
CYP2C9 is the major cytochrome P450 2C enzyme in human liver and contributes to the metabolism of a number of drugs. This enzyme shows genetic polymorphism with high inter‐ethnic variations, but no report has been addressed to the genetic polymorphism in Vietnamese population. Among 12 known allelic variations, CYP2C9*2 (Arg144Cys) and CYP2C9*3(Ile359Leu) genotypes have been most characterized due to its clinical relevance to cause enzymatic defects. Genetic polymorphism of these two alleles was determined in 157 Vietnamese subjects by PCR‐RFLP method and compared with those of other ethnics. CYP2C9*2 allele was not detected in Vietnamese, which was consistent with the previous results suggesting no occurrence of CYP2C9*2 allele in East Asians including Korean, Japanese, and Chinese. This frequency is highly different from those of Caucasians (10–13%) and American (8%). Out of 157 Vietnamese subjects, 7 subjects were heterozygous for CYP2C9*3 allele, which gave allelic frequency of 2.23%. In the context of the allelic frequency of CYP2C9*3, Vietnamese is not different from African‐American (0.5%) and East Asians including Korean (1.1%), Japanese (2.1%) and Chinese (1.7–2.6%), but significantly different from American (6%) and Caucasians (8–10%) (Chi‐square test, p<0.05). Our results indicate that genetic polymorphism of CYP2C9 in Vietnamese population is similar to those of East Asians, but significantly different from those of American and Caucasians.
British Journal of Clinical Pharmacology | 2007
Ho-Sook Kim; Y. Sunwoo; Ji Young Ryu; Ho-Jin Kang; Hye-Eun Jung; Im-Sook Song; Eun-Young Kim; Joo-Cheol Shim; Ji-Hong Shon; Jae-Gook Shin